Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Vertex pattern hair loss linked to higher prostate cancer risk.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Higher DHT in male baldness may protect against prostate cancer.

New compounds may help treat prostate cancer by reducing cell growth.

Physical activity, height, and smoking affect prostate cancer risk.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.